Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 01, 2023

BUY
$3.18 - $7.0 $111,300 - $245,000
35,000 New
35,000 $237,000
Q4 2021

Feb 02, 2022

SELL
$3.14 - $5.15 $86,193 - $141,367
-27,450 Closed
0 $0
Q3 2020

Oct 29, 2020

BUY
$8.49 - $19.54 $233,050 - $536,373
27,450 New
27,450 $243,000
Q3 2019

Nov 14, 2019

SELL
$19.17 - $27.4 $440,910 - $630,200
-23,000 Closed
0 $0
Q2 2019

Aug 01, 2019

BUY
$22.93 - $42.84 $527,390 - $985,320
23,000 New
23,000 $604,000

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $1.24B
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Deka Bank Deutsche Girozentrale Portfolio

Follow Deka Bank Deutsche Girozentrale and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.